Point of Care Molecular Diagnostics Market is expected to reach USD 1440.2 Million by 2023 from USD 725.5 Million in 2018, at a CAGR of 14.7%. Growth in the point-of-care (POC) molecular diagnostics market is mainly driven by factors such as the increasing worldwide prevalence of infectious diseases, rising focus on decentralized diagnostics, and the growing demand for CLIA-waived molecular POC tests.
Download Free Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=143524127
Point of Care Molecular Diagnostics Market by Product & Service (Assays, Kits, Analyzers, Software), Application (Respiratory Disease, Hospital Acquired Infection), Technology (RT-PCR, INAAT), End User (Physician Office, ICUS) – Global Forecast to 2023“, published by MarketsandMarkets™
Scope of the Report
The research report categorizes the global POC molecular diagnostics market into the following segments and subsegments:
To Know More @ https://www.marketsandmarkets.com/Market-Reports/point-of-care-molecular-diagnostic-market-143524127.html